Clinical Trial Update: Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone

View source ↗

Summary

Clinical trial update reports real-world Brazilian experience in castration-resistant prostate cancer patients treated with the combination of olaparib and abir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Olaparib (Olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Prostatic Neoplasms | Status: WITHDRAWN